Sachdeva M, Dhingra S, Parle M. Dapagliflozin: a new adjunct in the treatment of Type 2 diabetes mellitus. Int J Basic Clin Pharmacol [Internet]. 2017 Jan. 25 [cited 2026 Apr. 16];3(4):741-7. Available from: https://www.ijbcp.com/index.php/ijbcp/article/view/1067